Thompson M E, Zimmer W E, Haynes A L, Valentine D L, Forss-Petter S, Scammell J G
Department of Pharmacology, University of South Alabama, Mobile 36688.
Endocrinology. 1992 Jul;131(1):318-26. doi: 10.1210/endo.131.1.1612012.
The GH4C1 pituitary tumor cell line (GH cells) serves as a model system to study the role of the granins in the packaging of PRL into secretory granules. The number of secretory granules containing PRL and two members of the granin family, chromogranin-B (CgB) and secretogranin-II (SgII), can be hormonally manipulated. In the present study we have investigated whether 1) granulogenesis in GH cells is preceded by condensation of the granins and PRL in the Golgi; 2) granulogenesis is preceded by an increase in granin expression in GH cells; and 3) PRL and the granins aggregate in vitro under high calcium, low pH conditions. GH cells were treated for up to 3 days with 17 beta-estradiol (1 nM), insulin (300 nM), and epidermal growth factor (10 nM) and were fixed in 4% paraformaldehyde for immunocytochemistry or harvested for RNA isolation and Northern blot analysis. After 1 day of hormone treatment, there was a significant increase in staining for PRL and the granins in the Golgi apparatus, which was identified using an antibody to MG-160. After 3 days of hormone treatment, PRL and granin staining was also found in a perinuclear region that was not stained with anti-MG-160 antibody, most likely representing secretory granules. An increase in PRL and granin expression contributed to increased Golgi staining, as the steady state levels of CgB, SgII, and PRL mRNA increased 186 +/- 14%, 203 +/- 7%, and 337 +/- 5% above control levels, respectively, within 6 h after hormone treatment. An in vitro aggregation system was used to determine whether PRL and the granins coprecipitate under high calcium, low pH conditions, which are thought to be characteristic of the trans-Golgi and secretory granules. Aggregation of the granins CgB and SgII was negligible during overnight dialysis against a buffer containing 150 mM NaCl and 10 mM 2[N-morpholino]ethanesulfonic acid-NaOH (pH 5.5) in the absence of calcium. There was significant aggregation of PRL under these conditions. When dialysis was performed in the presence of 10 mM CaCl2, PRL, CgB, and SgII coaggregated. This study indicates that increased expression and aggregation of the granins is associated with PRL granulogenesis in hormone-treated GH cells. However, the role of the granins may not be obligatory, as some cells can store PRL in the absence of detectable levels of CgB and SgII, and PRL has the capacity to self-aggregate.
GH4C1垂体瘤细胞系(GH细胞)作为一个模型系统,用于研究嗜铬粒蛋白在催乳素(PRL)包装到分泌颗粒中的作用。含有PRL以及嗜铬粒蛋白家族的两个成员——嗜铬粒蛋白B(CgB)和分泌粒蛋白II(SgII)的分泌颗粒数量可通过激素调节。在本研究中,我们调查了:1)GH细胞中的颗粒形成是否先于高尔基体内嗜铬粒蛋白和PRL的凝聚;2)颗粒形成是否先于GH细胞中嗜铬粒蛋白表达的增加;3)PRL和嗜铬粒蛋白在体外高钙、低pH条件下是否会聚集。用17β-雌二醇(1 nM)、胰岛素(300 nM)和表皮生长因子(10 nM)处理GH细胞长达3天,然后用4%多聚甲醛固定用于免疫细胞化学分析,或收获细胞用于RNA分离和Northern印迹分析。激素处理1天后,使用抗MG-160抗体鉴定出高尔基体内PRL和嗜铬粒蛋白的染色显著增加。激素处理3天后,在未被抗MG-160抗体染色的核周区域也发现了PRL和嗜铬粒蛋白染色,很可能代表分泌颗粒。PRL和嗜铬粒蛋白表达的增加导致高尔基染色增加,因为激素处理后6小时内,CgB、SgII和PRL mRNA的稳态水平分别比对照水平增加了186±14%、203±7%和337±5%。使用体外聚集系统来确定PRL和嗜铬粒蛋白在高钙、低pH条件下是否会共沉淀,这种条件被认为是反式高尔基体和分泌颗粒的特征。在不存在钙的情况下,将嗜铬粒蛋白CgB和SgII与含有150 mM NaCl和10 mM 2-[N-吗啉代]乙磺酸-NaOH(pH 5.5)的缓冲液进行过夜透析时,嗜铬粒蛋白的聚集可以忽略不计。在这些条件下PRL有显著聚集。当在10 mM CaCl2存在的情况下进行透析时,PRL、CgB和SgII会共聚集。本研究表明,在激素处理的GH细胞中,嗜铬粒蛋白表达和聚集的增加与PRL颗粒形成有关。然而,嗜铬粒蛋白的作用可能不是必需的,因为一些细胞在未检测到CgB和SgII水平时也能储存PRL,并且PRL有自我聚集的能力。